SEOUL, South Korea: South Korean dental implant manufacturer OSSTEM IMPLANT is aiming to increase its market share in Japan, OSSTEM Japan CEO Kim Hae-gon told the Korean Times in an interview. Among other measures, the company plans to almost double its Japanese offices, from 12 to 22, by 2019.
Currently, the company, which was founded in 1997, holds only 3 per cent of the Japanese implant market. However, building on its success in South Korea, where the implant manufacturer has 50 per cent of the market share in the segment, OSSTEM plans to slowly expand its presence and over time compete with premium competitors from overseas, such as Straumann and Nobel Biocare. “The key behind our success in Korea is our strategy of not taking excessive royalty profits, but instead, investing more in research and development to enhance product quality,” Kim said.
Compared with Europe and America, the demand for implants is not yet as high in Japan. However, it is steadily growing and the company is confident that it will reach its annual sales target of JPY3 billion (US$27 million) by 2023. In 2016, OSSTEM Japan already generated JPY600 million (US$5.48 million) in sales, growing more than 150 per cent compared with its 2012 figures.
One reason for this success is the company’s focus on research and development, Kim said. Consequently, OSSTEM not only produces quality implants and dental equipment, but also puts emphasis on educating dental professionals in the field. For example, the company runs advanced education seminars for dentists wishing to learn surgical procedures for implant placement. “This is part of our efforts to raise the awareness of implants in Japan, which will also improve our brand image in the country,” the branch head remarked.
“It is true it will not be an overnight thing for us to make tons of profits in Japan in the next few years, but we are confident that the implants industry here will definitely take more concrete shape as time goes on. Our price-competitive and quality products will then pose serious threats to market leaders, as we had done with our products in Korea.”
Tags:
SYDNEY, Australia: An increasing number of Australians are wanting to repair malocclusion, and the demand for less intrusive and more cost-effective options...
VANCOUVER, Canada: When the global pandemic hit, dental treatments such as implant therapy were cancelled or rescheduled. This affected not only dental ...
ESCHBORN, Germany: Osstem Implant provides a comprehensive range of products for guided bone regeneration (GBR), including materials for volume-preserving ...
BURNABY, British Columbia, Canada: According to a new market report by iData Research, a leading provider of international dental market research, the Asia ...
SEOUL, South Korea: Osstem Implant, one of the world’s leading dental implant manufacturers, has published a new consensus statement outlining prosthetic ...
BURNABY, British Columbia, Canada: Digitalized dental products, whether produced by additive or subtractive technologies, are expected to disrupt the U.S. ...
LONDON, UK: The dental implants market in China is likely to exceed USD 696 million by 2020, growing at a CAGR of over 28%.The dental implants market in ...
SEOUL, South Korea: Osstem Implant is offering the 2024 OneGuide System: Fundamentals of Digital Guided Implant Surgery textbook to prominent dental schools...
VIENNA, Austria: For the first time, Osstem Implant, a global leader in dental implant technology and comprehensive dental solutions, will be participating ...
SEOUL, South Korea: This year, Osstem Implant is celebrating the 12th anniversary of introducing its flagship medical device, the K3 dental chair unit, to ...
Live webinar
Thu. 11 September 2025
1:00 pm EST (New York)
Live webinar
Mon. 15 September 2025
1:00 pm EST (New York)
Prof. Dr. med. dent. Stefan Wolfart
Live webinar
Tue. 16 September 2025
11:00 am EST (New York)
Prof. Dr. Dr. Florian Guy Draenert
Live webinar
Tue. 16 September 2025
12:30 pm EST (New York)
Dr. Kay Vietor, Birgit Sayn
Live webinar
Tue. 16 September 2025
1:00 pm EST (New York)
Dr. Paweł Aleksandrowicz PhD
Live webinar
Tue. 16 September 2025
8:00 pm EST (New York)
To post a reply please login or register